This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Abboud EC, Legare TB, Settle JC, et al. Do silver-based wound dressings reduce pain? A prospective study and review of the literature. Burns. 2014;40(suppl 1): S40–S47.AbboudECLegareTBSettleJCDo silver-based wound dressings reduce pain? A prospective study and review of the literature201440suppl 1S40S47Search in Google Scholar
Benbow M. Best practice in wound assessment. Nurs Stand. 2016;30(27):40–47.BenbowMBest practice in wound assessment201630274047Search in Google Scholar
Lo SF, Hayter M, Hu WY, Tai CY, Hsu MY, Li YF. Symptom burden and quality of life in patients with malignant fungating wounds. J Adv Nurs. 2012;68(6):1312–1321.LoSFHayterMHuWYTaiCYHsuMYLiYFSymptom burden and quality of life in patients with malignant fungating wounds201268613121321Search in Google Scholar
Adderley U.J., Holt I.G. Topical agents and dressings for fungating wounds. Cochrane Database Syst Rev. 2014;(5):CD003948.AdderleyU.J.HoltI.G.Topical agents and dressings for fungating wounds20145CD003948Search in Google Scholar
Alexander S. Malignant fungating wounds: key symptoms and psychosocial issues. J Wound Care. 2009;18: 325–329.AlexanderSMalignant fungating wounds: key symptoms and psychosocial issues200918325329Search in Google Scholar
Fromantin I, Watson S, Baffie A, et al. A prospective, descriptive cohort study of malignant wound characteristics and wound care strategies in patients with breast cancer. Ostomy Wound Manage. 2014;60(6):38–48.FromantinIWatsonSBaffieAA prospective, descriptive cohort study of malignant wound characteristics and wound care strategies in patients with breast cancer20146063848Search in Google Scholar
Samala RV, Davis MP. Comprehensive wound malodor management: win the RACE. Cleve Clin J Med. 2015;82(8):535–543.SamalaRVDavisMPComprehensive wound malodor management: win the RACE2015828535543Search in Google Scholar
Langemo DK, Anderson J, Hanson D, Hunter S, Thompson P. Managing fungating wounds. Adv Skin Wound Care. 2007;20(6):312–314.LangemoDKAndersonJHansonDHunterSThompsonPManaging fungating wounds2007206312314Search in Google Scholar
Probst S, Arber A, Faithfull S. Malignant fungating wounds: a survey of nurses’ clinical practice in Switzerland. Eur J Oncol Nurs. 2009;13(4):295–298.ProbstSArberAFaithfullSMalignant fungating wounds: a survey of nurses’ clinical practice in Switzerland2009134295298Search in Google Scholar
Thomas S, Fisher B, Fram PJ, Waring MJ. Odour-absorbing dressings. J Wound Care. 1998;7(5):246–250.ThomasSFisherBFramPJWaringMJOdour-absorbing dressings199875246250Search in Google Scholar
Ramasubbu DA, Smith V, Hayden F, Cronin P. Systemic antibiotics for treating malignant wounds. Cochrane Database Syst Rev. 2017;8:CD011609.RamasubbuDASmithVHaydenFCroninPSystemic antibiotics for treating malignant wounds20178CD011609Search in Google Scholar
Samala RV, Davis MP. Comprehensive wound malodor management: win the RACE. Cleve Clin J Med. 2015;82(8):535–543.SamalaRVDavisMPComprehensive wound malodor management: win the RACE2015828535543Search in Google Scholar
Bower M, Stein R, Evans TR, Hedley A, Pert P, Coombes RC. A double-blind study of the efficacy of metronidazole gel in the treatment of malodorous fungating tumours. Eur J Cancer. 1992;28a(4–5):888–889.BowerMSteinREvansTRHedleyAPertPCoombesRCA double-blind study of the efficacy of metronidazole gel in the treatment of malodorous fungating tumours199228a4–5888889Search in Google Scholar
Watanabe K, Shimo A, Tsugawa K, et al. Safe and effective deodorization of malodorous fungating tumors using topical metronidazole 0.75% gel (GK567): a multicenter, open-label, phase III study (RDT.07.SRE.27013). Support Care Cancer. 2016;24(6):2583–2590.WatanabeKShimoATsugawaKSafe and effective deodorization of malodorous fungating tumors using topical metronidazole 0.75% gel (GK567): a multicenter, open-label, phase III study (RDT.07.SRE.27013)201624625832590Search in Google Scholar
Kuge S, Tokuda Y, Ohta M, et al. Use of metronidazole gel to control malodor in advanced and recurrent breast cancer. Jpn J Clin Oncol. 1996;26(4):207–210.KugeSTokudaYOhtaMUse of metronidazole gel to control malodor in advanced and recurrent breast cancer1996264207210Search in Google Scholar
Adderley UJ, Holt IG. Topical agents and dressings for fungating wounds. Cochrane Database Syst Rev. 2014(5):CD003948.AdderleyUJHoltIGTopical agents and dressings for fungating wounds20145CD003948Search in Google Scholar
Akhmetova A, Saliev T, Allan IU, Illsley MJ, Nurgozhin T, Mikhalovsky S. A comprehensive review of topical odor-controlling treatment options for chronic wounds. J Wound Ostomy Continence Nurs. 2016;43(6):598–609.AkhmetovaASalievTAllanIUIllsleyMJNurgozhinTMikhalovskySA comprehensive review of topical odor-controlling treatment options for chronic wounds2016436598609Search in Google Scholar
Coombs TJ. Product profile: more than a wound dressing. Health Soc Serv J. 1981;91(4768):1268–1269.CoombsTJProduct profile: more than a wound dressing198191476812681269Search in Google Scholar
Graham C. The role of silver in wound healing. Br J Nurs. 2005;14(19): S22, S24, S26.GrahamCThe role of silver in wound healing20051419S22, S24, S26.Search in Google Scholar
Kalemikerakis J, Vardaki Z, Fouka G, et al. Comparison of foam dressings with silver versus foam dressings without silver in the care of malodorous malignant fungating wounds. J Buon. 2012;17(3):560–564.KalemikerakisJVardakiZFoukaGComparison of foam dressings with silver versus foam dressings without silver in the care of malodorous malignant fungating wounds2012173560564Search in Google Scholar